I
immunization
Pronunciation (im′myū-ni-zā′shŭn)
Protection of susceptible patients from communicable diseases by administration of a living modified agent (e.g., yellow fever vaccine), a suspension of killed organisms (e.g., pertussis vaccine), a protein expressed in a heterologous organism (e.g., hepatitis B vaccine), or an inactivated toxin (e.g., tetanus). See also: vaccination, allergization. (Back to Glossary)
impotence
Pronunciation (im′pŏ-tens, -ten-sē)
Weakness; lack of power.
Specifically, inability of the male to achieve or maintain penile erection and thus engage in copulation; a manifestation of neurologic, vascular, or psychological dysfunction. (Back to Glossary)
influenza
Pronunciation (in′flū-en′ză)
An acute infectious respiratory disease, caused by Influenza viruses, which are in the family Orthomyxoviridae, in which the inhaled virus attacks the respiratory epithelial cells of those susceptible and produces a catarrhal inflammation; characterized by sudden onset, chills, fever of short duration (3–4 days), severe prostration, headache, muscle aches, and a cough that usually is dry and may be followed by secondary bacterial infections that can last up to 10 days. The disease commonly occurs in epidemics, sometimes in pandemics, which develop quickly and spread rapidly; the mortality rate is usually low, but may rise in patients with secondary bacterial pneumonia, particularly in old people and those with underlying debilitating diseases; strain-specific immunity develops, but mutations in the virus are frequent, and such immunity usually does not affect antigenically different. (Back to Glossary)
insulin
Pronunciation (in′sŭ-lin)
A polypeptide hormone, secreted by β cells in the islets of Langerhans, which promotes glucose use, protein synthesis, and the formation and storage of neutral lipids; available in various preparations including genetically engineered human insulin, which is currently favored. Insulin is used parenterally in the treatment of diabetes mellitus. (Back to Glossary)
insulin resistance
Diminished effectiveness of insulin in lowering plasma glucose levels, arbitrarily defined as a daily requirement of at least 200 units of insulin to prevent hyperglycemia or ketosis; usually due to binding of insulin or insulin receptor sites by antibodies; associated with obesity, ketoacidosis, and infection. See also: metabolic syndrome. (Back to Glossary)